Fortis Healthcare Ltd (FORTIS) Q1FY27 Concall Summary - Jun-2026 Qtr
Performance Overview
- The company reported a positive start to the financial year, demonstrating steady performance across both its hospital and diagnostics businesses, building on the momentum from the previous year.
- Consolidated revenues saw a significant growth of 17.5% year-over-year, driven by a strong 19% increase in the hospital business and a 10.2% rise in the diagnostics segment.
- The hospital business maintained a stable occupancy rate of 69% despite a 17% increase in the number of occupied beds, indicating successful integration of recent acquisitions and brownfield expansions.
- The company continues its strategic expansion, adding 100 operational beds during the quarter and entering the Orissa market through a new 300-bed O&M agreement, expanding its presence in growth markets.
- Management reaffirmed its long-term guidance of achieving a 25% EBITDA margin by FY28, expressing confidence that the impact of ESOP costs will be offset by operational efficiencies, growth from new facilities, and other cost-saving measures.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.